Showing results (81-90 of 1,944) with videos related to

Sort By:
Pageof 195
RMD Open|May 9, 2025
Effect of depressive symptoms on treatment response in patients with axSpA: data from the RABBIT-SpA registerAndreas Reich, Anja Weiß, Lisa Lindner, et al.
RMD Open|May 9, 2025
Time sequence of autoimmune processes in the trajectory to rheumatoid arthritis development: what do we know?Judith W Heutz, René E M Toes, Annette H M van der Helm-van Mil
RMD Open|May 9, 2025
Metabolomic profiles underlying gout flares: a prospective study of people with goutWenyan Sun, Rui Li, Nicola Dalbeth, et al.
RMD Open|February 16, 2026
Improvements in quality-of-life dimensions through medium-chain triglyceride (MCT) supplementation in rheumatoid arthritis: updated findings from a randomised clinical trialGiulia Gaudioso, Patrizia Zanon, Silvano Ciani, et al.
RMD Open|January 22, 2026
Impact of ANCA specificity on risk of cardiovascular events and death in ANCA-associated vasculitisJon Idoate Lacasia, Morgane Mourguet, Thomas Villeneuve, et al.
RMD Open|January 27, 2026
Transcriptomic and proteomic analysis stratifies patients with axial spondyloarthritis based on disease activity, structural damage and radiographic progressionLaura Cuesta-López, Iván Arias-de la Rosa, Carlos Pérez-Sánchez, et al.
RMD Open|November 10, 2017
Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trialMarieke M Ter Wee, Veerle Mh Coupé, Debby den Uyl, et al.
RMD Open|November 10, 2017
Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosusHelena Tydén, Christian Lood, Birgitta Gullstrand, et al.
RMD Open|November 30, 2018
ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI)Janet E Pope, Mohammad Movahedi, Emmanouil Rampakakis, et al.
RMD Open|November 30, 2018
Comparative analyses of responsiveness between the Rheumatoid Arthritis Impact of Disease score, other patient-reported outcomes and disease activity measures: secondary analyses from the ARCTIC studyKaren Holten, Joseph Sexton, Tore K Kvien, et al.
Pageof 195